stockportfolio.pro
Stocks / AHG vs CDNA
AHG vs CDNA
Akso Health Group and CareDx, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Akso Health Group (AHG) | CareDx, Inc. (CDNA) | |
|---|---|---|
| Market cap | $1.2B | $1.2B |
| Revenue (latest FY) | $14.78M | $379.81M |
| Net income (latest FY) | $-134.98M | $-21.35M |
| Revenue growth (5y CAGR) | 35.0% | 14.6% |
| Net margin | -913.4% | -5.6% |
| Return on equity | -67.8% | -7.0% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 1 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open AHG — free Open CDNA — freeFrequently asked questions
Which is bigger, AHG or CDNA?
Akso Health Group is larger by market capitalization — $1.2B versus $1.2B.
Which grows faster, AHG or CDNA?
Over the last five fiscal years, Akso Health Group grew revenue faster — 35.0%/yr versus 14.6%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.